Pulmonary Embolism: Mechanism and Therapeutic Innovation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
- 主要终点
- Survival Rate of Patients
研究概览
简要总结
To explore the pathogenesis, therapy and outcome of pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).
详细描述
The study recruited consecutive outpatients or hospitalized patients diagnosed with pulmonary embolism (PE cohort) and chronic thromboembolic pulmonary hypertension (CTEPH cohort). The follow-up of all patients was performed annually by phone or outpatient visit. The main outcomes were bleeding, recurrent events, and survival. The objective of the study was to explore the pathogenesis, therapy and outcome of PE and CTEPH.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All hospitalized patients or outpatients diagnosed with PE or CTEPH;
排除标准
- •Refused informed consents.
结局指标
主要结局
Survival Rate of Patients
时间窗: through study completion, an average of 1 year.
Events were recored by follow-up.
Recurrent Incidence of Patients
时间窗: through study completion, an average of 1 year.
Recurrent PE was measured by computed tomography pulmonary angiography (CTPA) or ventilation/perfusion (V/Q) lung scans. Recurrent deep venous thrombosis was measured by lower extremity Doppler ultrasound.
Bleeding Rate of Patients
时间窗: through study completion, an average of 1 year.
Events were recored by follow-up.
次要结局
未报告次要终点
研究者
Lu Hua
Director, Center for Respiratory and Pulmonary Vascular Diseases，Principal Investigator, Clinical Professor
China National Center for Cardiovascular Diseases